BRIEF-Valeant considering disposal of Obagi Medical Products as well as Provenge - Bloomberg
May 17 (Reuters) -
* Valeant Pharmaceuticals considering disposal Of Obagi Medical Products Inc, dermatology company it acquired in 2013, as well as Provenge - Bloomberg
* Valeant Pharmaceuticals may sell drugs acquired from Marathon Pharmaceuticals last year - Bloomberg citing source
* Valeant Pharmaceuticals divestitures could raise as much as $1 billion and attract other drugmakers with an interest in those areas - Bloomberg Source: (bloom.bg/1WBHJIN) Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
© Thomson Reuters 2017 All rights reserved.